Učitavanje...
Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines
PURPOSE: Acquired resistance to erlotinib in patients with EGFR-mutant non-small cell lung cancer can result from aberrant activation of alternative receptor tyrosine kinases, such as the HGF-driven c-MET receptor. We sought to determine whether inhibition of AKT signaling could augment erlotinib ac...
Spremljeno u:
| Izdano u: | J Cancer Res Clin Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4562434/ https://ncbi.nlm.nih.gov/pubmed/25323938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-014-1855-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|